Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Multiple sclerosis and sexual dysfunction.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Is multiple sclerosis an autoimmune disease?
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Naltrexone prescribing information
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.

Pages